Prevalence Of Pelvic Floor Dysfunction In Patients With Interstitial Cystitis

August 26, 2007 – 6:58 pm | posted in Urology / Nephrology

UroToday.com- Many IC patients also suffer from pelvic floor spasm, which causes pelvic pain, dyspareunia, and urinary hesitancy. In this article, Peters and colleagues from Royal Oak, Michigan evaluated 70 women with IC and pelvic pain. They found that 87% had levator pain and 71% had dyspareunia. The average levator pain score was 4.48 out of 10. 11 women had an Interstim device and 1 had a Bion Microstimulator. All neuromodulation units were functioning at the time of evaluation with the overall levator pain score significantly higher in the neuromodulation subgroup (7.2 vs. 3.87) than in those without neurostimulation. Half of the women reported irritable bowel syndrome, urinary incontinence was reported in one-third of the patients evaluated, and pain intensity was independent of pain duration.

The authors speculate that neural pathways coordinating smooth and striated muscle activity of the pelvic organs may respond to ongoing long-term stimulation by negatively impacting the nonirritated pelvic organs. This may lead to neurogenic inflammation and sensitization through the release of neurotrophic factors. It has been proposed that a noxious stimulus may trigger the release of nerve growth factor and substance P in the periphery causing the mast cells in the bladder to release proinflammatory substances leading to neurogenic inflammation of the bladder wall. This can result in BPS symptoms or vulvar or vaginal pain. The pelvic floor dysfunction may lead to voiding difficulties and ultimately urinary urgency, frequency, and pelvic pain.

Peters and colleagues suggest that if one suspect’s pelvic floor dysfunction myofascial release may be offered as a first line of treatment. If bladder symptoms fail to respond then medical or surgical therapies directed toward the bladder can be provided.

Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC

Urology. 70(1):16-18, July 2007
doi:10.1016/j.urology.2007.02.067

Reported by UroToday.com Contributing Editor Philip M Hanno, M.D

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

Also Read

  • Hyaluronic Acid: An Effective Alternative Treatment Of Interstitial Cystitis, Recurrent Urinary Tract Infections, And Hemorrhagic Cystitis?
  • Sensitization Of Pelvic Nerve Afferents And Mast Cell Infiltration In The Urinary Bladder Following Chronic Colonic Irritation Is Mediated By Neuropep
  • Bowel Dysfunction After Transposition Of Intestinal Segments Into The Urinary Tract: 8-Year Prospective Cohort Study
  • Some Factors Related To Heart Function And Linked With Heart Failure More Common Than Believed
  • Damage To Muscle During Vaginal Deliveries Connected With Pelvic Organ Prolapse Later In Life
  • CryoLife Receives FDA Approval For Soft-Tissue Repair Product That Can Be Used For Vaginal Prolapse
  • Early Feeding Could Help Reduce Liver Dysfunction In Critically Ill Patients
  • MediciNova Announces The Initiation Of The Phase III Clinical Program For MN-001, A Novel Oral Treatment For Bronchial Asthma
  • Ovarian cancer or ovarian pain?
  • Winners Of The Second Embrace Journalism Award For Reporting On Urinary Incontinence Are Announced
  • You must be logged in to post a comment.